(XTLB) Xtl Biopharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xtl Biopharmaceuticals | (XTLB) share price targets
Complete technical analysis of Xtl Biopharmaceuticals (XTLB) by charts plus indicators, forecast predictions and share price targets for Xtl Biopharmaceuticals (XTLB)
Xtl Biopharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-26 View latest technical analysis
10 day averaged volume of Xtl Biopharmaceuticals is 5100
Date | Daily Closing Price | Open | High | Low | Volume |
26 Thu Sep 2024 | 2.53 | 2.52 | 2.53 | 2.51 | 1.392 times |
25 Wed Sep 2024 | 2.59 | 2.45 | 2.59 | 2.45 | 0.373 times |
24 Tue Sep 2024 | 2.44 | 2.45 | 2.45 | 2.33 | 2.588 times |
23 Mon Sep 2024 | 2.42 | 2.25 | 2.47 | 2.25 | 0.941 times |
20 Fri Sep 2024 | 2.44 | 2.42 | 2.44 | 2.36 | 0.765 times |
19 Thu Sep 2024 | 2.42 | 2.40 | 2.45 | 2.35 | 0.392 times |
18 Wed Sep 2024 | 2.41 | 2.41 | 2.41 | 2.40 | 0.353 times |
17 Tue Sep 2024 | 2.45 | 2.49 | 2.49 | 2.30 | 2.137 times |
16 Mon Sep 2024 | 2.54 | 2.48 | 2.54 | 2.47 | 1.176 times |
13 Fri Sep 2024 | 2.63 | 2.47 | 2.63 | 2.47 | 0.392 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2.5 as stoploss in an intra day buy trade for a target of 2.59. However, stock will show a bearish move below 2.5.
Share price targets for Xtl Biopharmaceuticals (XTLB)
Target Type | Value |
Downside Target | 1.85 |
Downside Target | 2.10 |
Downside Target | 2.16 |
Downside Target | 2.25 |
Downside Target | 2.30 |
Downside Target | 2.39 |
Downside Target | 2.47 |
Upside Target | 2.54 |
Upside Target | 2.70 |
Upside Target | 2.79 |
Upside Target | 2.81 |
Upside Target | 2.97 |
Upside Target | 3.05 |
Upside Target | 3.15 |
Intraday share price targets for Xtl Biopharmaceuticals (XTLB)
Target Type | Value |
Downside Intraday Target | 2.32 |
Downside Intraday Target | 2.12 |
Upside Intraday Target | 2.66 |
Upside Intraday Target | 2.8 |
Downside Intraday Target | 2.46 |
Weekly technical analysis of Xtl Biopharmaceuticals (XTLB)
Date | Weekly Closing Price | Open | High | Low | Volume |
26 Thu Sep 2024 | 2.53 | 2.25 | 2.59 | 2.25 | 1.098 times |
20 Fri Sep 2024 | 2.44 | 2.48 | 2.54 | 2.30 | 0.969 times |
13 Fri Sep 2024 | 2.63 | 2.70 | 2.70 | 2.47 | 0.508 times |
06 Fri Sep 2024 | 2.70 | 2.79 | 2.79 | 2.56 | 71.429 times |
30 Fri Aug 2024 | 2.79 | 2.65 | 2.79 | 2.54 | 0.017 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xtl Biopharmaceuticals (XTLB)
Date | Monthly Closing Price | Open | High | Low | Volume |
26 Thu Sep 2024 | 2.53 | 2.79 | 2.79 | 2.25 | 0.675 times |
30 Fri Aug 2024 | 2.79 | 2.85 | 2.97 | 2.39 | 0.503 times |
31 Wed Jul 2024 | 2.88 | 2.39 | 3.05 | 2.16 | 0.656 times |
28 Fri Jun 2024 | 2.43 | 2.57 | 2.81 | 1.85 | 2.184 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xtl Biopharmaceuticals (XTLB)
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term and the sell signal is strong.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Xtl Biopharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Xtl Biopharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.47 and Xtl Biopharmaceuticals (XTLB) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term and the sell signal is strong.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Xtl Biopharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Xtl Biopharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.47 and Xtl Biopharmaceuticals (XTLB) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.